| Source HCPCS Code |
|
Target NDC Code |
Q5132
INJECTION, ADALIMUMAB-AFZB (ABRILADA), BIOSIMILAR, 10 MG
|
⇄
|
00025-0325-01
ABRILADA PEN (PF,LATEX-FREE) 40 MG/0.8 ML
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
SC |
| Billing Units |
EA |
|
|
|
Q5132
INJECTION, ADALIMUMAB-AFZB (ABRILADA), BIOSIMILAR, 10 MG
|
⇄
|
00025-0325-02
ABRILADA PEN (PF,LATEX-FREE) 40 MG/0.8 ML
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
SC |
| Billing Units |
EA |
|
|
|
Q5132
INJECTION, ADALIMUMAB-AFZB (ABRILADA), BIOSIMILAR, 10 MG
|
⇄
|
00025-0328-02
ABRILADA (PF,LATEX-FREE) 40 MG/0.8 ML
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
SC |
| Billing Units |
EA |
|
|
|
Q5132
INJECTION, ADALIMUMAB-AFZB (ABRILADA), BIOSIMILAR, 10 MG
|
⇄
|
00025-0333-02
ABRILADA (PF,LATEX-FREE) 20 MG/0.4 ML
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
SC |
| Billing Units |
EA |
|
|
|
Q5132
INJECTION, ADALIMUMAB-AFZB (ABRILADA), BIOSIMILAR, 10 MG
|
⇄
|
00069-0325-01
ABRILADA PEN (PF,LATEX-FREE) 40 MG/0.8 ML
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
SC |
| Billing Units |
EA |
|
|
|
Q5132
INJECTION, ADALIMUMAB-AFZB (ABRILADA), BIOSIMILAR, 10 MG
|
⇄
|
00069-0325-02
ABRILADA PEN (PF,LATEX-FREE) 40 MG/0.8 ML
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
SC |
| Billing Units |
EA |
|
|
|
Q5132
INJECTION, ADALIMUMAB-AFZB (ABRILADA), BIOSIMILAR, 10 MG
|
⇄
|
00069-0328-02
ABRILADA (PF,LATEX-FREE) 40 MG/0.8 ML
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
SC |
| Billing Units |
EA |
|
|
|
Q5132
INJECTION, ADALIMUMAB-AFZB (ABRILADA), BIOSIMILAR, 10 MG
|
⇄
|
00069-0333-02
ABRILADA (PF,LATEX-FREE) 20 MG/0.4 ML
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
SC |
| Billing Units |
EA |
|
|
|